|
|
Vaccine Detail
|
CLL Idiotypic DNA Vaccine |
| Vaccine Information |
- Vaccine Name: CLL Idiotypic DNA Vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: DNA vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Immunization Route: Other
- Description: The vaccines treats patients with Binet Stage A Chronic Lymphocytic Leukemia (CLL) by using a fragment of Deoxyribonucleic acid (DNA) containing the sequence of their own immunoglobulin gene. The vaccine is designed to generate an immune response and shrink or slow the CLL. (NCT00038415)
|
| Host Response |
|
|
| References |
NCT00038415: A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach [https://clinicaltrials.gov/study/NCT00038415]
|
|
